Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in DFTX — Definium Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC
Back to DFTX Full portfolio

Position in DFTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,741,606
+$4,748,886 QoQ
Shares Held
164,575
+3.9% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in DFTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. DFTX ranks #125 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in DFTX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,741,606 164,575
2026-03-31 $2,992,720 158,345